93 related articles for article (PubMed ID: 6172351)
21. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
[No Abstract] [Full Text] [Related]
22. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
Bertelé V; Falanga A; Tomasiak M; Cerletti C; de Gaetano G
Thromb Haemost; 1984 Feb; 51(1):125-8. PubMed ID: 6326343
[TBL] [Abstract][Full Text] [Related]
23. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
24. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
25. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
Glenn JR; Heptinstall S
Thromb Haemost; 1998 Aug; 80(2):321-5. PubMed ID: 9716160
[TBL] [Abstract][Full Text] [Related]
26. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
27. Effects of prostacyclin on fetal platelet function.
Matsumoto T; Kihira M; Ito M; Sugiyama Y
Biol Res Pregnancy Perinatol; 1984; 5(1):11-5. PubMed ID: 6322874
[TBL] [Abstract][Full Text] [Related]
28. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
[TBL] [Abstract][Full Text] [Related]
29. [Adenyl cyclase activity in the thrombocytes of patients with ischemic heart disease].
Ozerova IN; Gerasimova EN; Chazova LV
Ter Arkh; 1975; 47(7):72-6. PubMed ID: 1224354
[No Abstract] [Full Text] [Related]
30. [Role of adenylate cyclase and the mechanism controlling platelet aggregation].
Yoshida N; Aoki N
Rinsho Byori; 1979; Suppl 40():47-53. PubMed ID: 233107
[No Abstract] [Full Text] [Related]
31. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
Oliva D; Giovanazzi S; Lograno M; Mongelli N; Corsini A; Fumagalli R; Nicosia S
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():172-5. PubMed ID: 2526466
[No Abstract] [Full Text] [Related]
32. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function.
Whiss PA; Lundahl TH; Bengtsson T; Lindahl TL; Lunell E; Larsson R
Toxicol Appl Pharmacol; 2000 Mar; 163(2):95-104. PubMed ID: 10698667
[TBL] [Abstract][Full Text] [Related]
34. The effect of a medicinal Chinese herb on platelet function.
Wang Z; Roberts JM; Grant PG; Colman RW; Schreiber AD
Thromb Haemost; 1982 Dec; 48(3):301-6. PubMed ID: 6298967
[TBL] [Abstract][Full Text] [Related]
35. Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control.
Kajita K; Ishizuka T; Miura A; Kanoh Y; Ishizawa M; Kimura M; Yasuda K
Platelets; 2001 Sep; 12(6):343-51. PubMed ID: 11672473
[TBL] [Abstract][Full Text] [Related]
36. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
37. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets.
Graber SE; Hawiger J
J Biol Chem; 1982 Dec; 257(24):14606-9. PubMed ID: 6294072
[TBL] [Abstract][Full Text] [Related]
38. [Change in the adenylate cyclase activity of the lymphocytes and thrombocytes in irradiated sheep].
Shevchenko AS
Radiobiologiia; 1990; 30(3):308-11. PubMed ID: 2164696
[TBL] [Abstract][Full Text] [Related]
39. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
Oliva D; Nicosia S
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
[No Abstract] [Full Text] [Related]
40. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
